Earnings History Data for Invitae Corporation (NVTA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Invitae Corporation

Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2023	AH		NVTA	Invitae Corporation	178.34	-0.10	-0.30	-0.42	Invitae Non-GAAP EPS of -$0.10 beats by $0.22, revenue of $121.24M in-line [11/8/2023 4:02 PM]	0.4235	-0.27 (-38.55%)	0.62	-0.07 (-10.19%)	0.36 - 3.78	26,521,990	6,430,000	170,722
Invitae Non-GAAP EPS of -$0.10 beats by $0.22, revenue of $121.24M in-line [11/8/2023 4:02 PM]
08-08-2023	AH		NVTA	Invitae Corporation	320.63	-0.30	-0.37	-0.68	Invitae Non-GAAP EPS of -$0.30 beats by $0.07, revenue of $120.5M beats by $0.32M [8/8/2023 4:03 PM]	1.11	-0.09 (-7.50%)	1.14	-0.06 (-5.00%)	1.02 - 9.00	11,993,888	6,750,000	88,446
Invitae Non-GAAP EPS of -$0.30 beats by $0.07, revenue of $120.5M beats by $0.32M [8/8/2023 4:03 PM]
09-05-2023	AH	4:05 PM ET (May 9)	NVTA	Invitae Corporation	399.56	-0.37	-0.41	-0.78	Invitae Non-GAAP EPS of -$0.37 beats by $0.03, revenue of $117.36M beats by $0.79M [5/9/2023 4:12 PM]	1.48	-0.13 (-8.07%)	1.39	-0.22 (-13.66%)	1.17 - 9.00	12,315,927	7,730,000	685,606
Invitae Non-GAAP EPS of -$0.37 beats by $0.03, revenue of $117.36M beats by $0.79M [5/9/2023 4:12 PM] Invitae down 11% after hours despite quarterly beats [5/9/2023 4:42 PM]
28-02-2023	AH	4:05 PM ET (Feb 28)	NVTA	Invitae Corporation	500.36	-0.34	-0.55	-0.81	Invitae Non-GAAP EPS of -$0.34 beats by $0.19, revenue of $122.45M beats by $1.47M [2/28/2023 4:13 PM]	1.66	-0.49 (-23.02%)	2.12	-0.03 (-1.40%)	1.61 - 11.33	30,971,309	7,670,000	49,812
Invitae Non-GAAP EPS of -$0.34 beats by $0.19, revenue of $122.45M beats by $1.47M [2/28/2023 4:13 PM] Invitae announces senior notes transaction with Deerfield [2/28/2023 6:21 PM] Invitae slumps 23% on 2023 guidance, debt agreement [3/1/2023 12:32 PM]
08-11-2022	AH	4:05 PM ET (Nov 8)	NVTA	Invitae Corporation	590.52	-0.42	-0.59	-0.81	Invitae GAAP EPS of -$1.27 misses by $0.43, revenue of $133.54M beats by $2.16M [11/8/2022 4:11 PM]	2.27	-0.08 (-3.19%)	2.53	0.18 (7.66%)	1.83 - 23.40	23,214,873	9,060,000	101,154
Invitae GAAP EPS of -$1.27 misses by $0.43, revenue of $133.54M beats by $2.16M [11/8/2022 4:11 PM] Invitae Reports Third Quarter 2022 Financial Results [Nov-08-22 04:05PM] Invitae (NVTA) Q3 2022 Earnings Call Transcript [Nov-08-22 09:00PM] Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-22 05:55PM]
09-08-2022	AH	4:05 PM ET (Aug 9)	NVTA	Invitae Corporation	502.14	-0.68	-0.74	-0.85	Invitae Non-GAAP EPS of -$0.68 beats by $0.08, revenue of $136.6M beats by $0.55M [8/9/2022 4:08 PM]	8.25	5.96 (260.26%)	2.51	0.22 (9.61%)	1.83 - 32.93	209,628,402	9,860,000	209,276
Invitae Non-GAAP EPS of -$0.68 beats by $0.08, revenue of $136.6M beats by $0.55M [8/9/2022 4:08 PM] Invitae maintains 2022 financial guidance as Q2 results beat on top and bottom lines [8/9/2022 6:15 PM] Invitae rises 57% behind 2022 financial guidance, quarterly beats [8/10/2022 12:57 PM] Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates [Aug-08-22 06:25PM] New NCCN Colorectal Cancer Guidelines Recommend Genetic Testing for All Diagnosed Patients [Aug-08-22 11:45AM]
03-05-2022	AH	4:05 PM ET (May 3)	NVTA	Invitae	1,196	-0.78	-0.77	0.00	Invitae Non-GAAP EPS of -$0.78 misses by $0.02, revenue of $123.69M misses by $5.62M [5/3/2022 4:08 PM]	5.97	0.41 (7.27%)	5.39	-0.18 (-3.23%)	4.63 - 35.51	10,888,489	7,010,000	64,370
Invitae Non-GAAP EPS of -$0.78 misses by $0.02, revenue of $123.69M misses by $5.62M [5/3/2022 4:08 PM] Invitae Q1 net loss widens 66% amid rise in R&D, marketing expenses (updated) [5/3/2022 4:41 PM] Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast Cancer [May-03-22 06:00AM] 10 Best Stocks to Buy Under $20 According to Jeremy Greens Redmile Group [May-03-22 08:55AM] Invitae Reports $123.7 Million in Revenue in First Quarter of 2022 and Extends Cash Runway [May-03-22 04:05PM] Invitae (NVTA) Reports Q1 Loss, Lags Revenue Estimates [May-03-22 05:45PM] Invitae (NVTA) Q1 2022 Earnings Call Transcript [May-03-22 10:00PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	NVTA	Invitae Corporation	2,030	-0.81	-0.74	-0.63	Invitae Non-GAAP EPS of -$0.81 misses by $0.04, revenue of $126.1M beats by $0.2M [2/24/2022 4:16 PM]	10.32	0.92 (9.79%)	9.30	-0.10 (-1.06%)	8.10 - 44.55	4,739,741	5,910,000	863
Invitae Non-GAAP EPS of -$0.81 misses by $0.04, revenue of $126.1M beats by $0.2M [2/24/2022 4:16 PM] Invitae sees quarterly net loss narrow but still misses on bottom line [2/24/2022 4:37 PM] Cathie Wood is Doubling Down on These 10 Stocks Despite Losses [Feb-23-22 10:59AM] 10 Genomics Stocks in Cathie Woods Portfolio That Are Underperforming [Feb-23-22 09:54AM] This Week's 5 Must-See Earnings Charts [Feb-24-22 10:56AM] Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021 [Feb-24-22 04:05PM] Invitae (NVTA) Reports Q4 Loss, Tops Revenue Estimates [Feb-24-22 06:10PM]
08-11-2021	AH	4:05 PM ET (Nov 8)	NVTA	Invitae Corporation	5,780	-0.81	-0.69	-0.62	Invitae EPS beats by $0.01, misses on revenue [11/8/2021 4:09 PM]	20.50	-5.77 (-21.96%)	22.69	-3.58 (-13.63%)	20.49 - 61.59	13,528,420	2,030,000	297,438
Invitae EPS beats by $0.01, misses on revenue [11/8/2021 4:09 PM] Inivitae drops 12% after adjusted 2021 revenue outlook falls below estimates [11/8/2021 4:43 PM] Invitae hit with DoJ subpoena over sponsored testing programs [11/9/2021 6:05 PM] Northwestern University and Invitae Present New Research Highlighting the Importance of Genetic Testing for Cardiovascular Conditions at the American Heart Association Scientific Sessions [Nov-08-21 08:00AM] Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third Quarter of 2021 [Nov-08-21 04:05PM] Invitae (NVTA) Reports Q3 Loss, Lags Revenue Estimates [Nov-08-21 05:35PM] Invitae (NVTA) Q3 2021 Earnings Call Transcript [Nov-09-21 03:30AM] 3 Stocks That Could Soar 46% or More, According to Wall Street [Nov-09-21 06:13AM]
03-08-2021	AH	4:05 PM ET (Aug 3)	NVTA	Invitae Corporation	5,590	-0.85	-0.65	-0.77	Invitae EPS beats by $0.06, beats on revenue [8/3/2021 4:07 PM]	30.92	2.42 (8.49%)	30.92	0.0 (0.00%)	25.24 - 61.59	6,700,241	2,490,000	64,942
Invitae EPS beats by $0.06, beats on revenue [8/3/2021 4:07 PM] Invitae shares rise on Q2 earnings beat, FY revenue forecast raise [8/3/2021 4:20 PM] Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021 [Aug-03-21 04:05PM] Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-21 07:35PM] Invitae (NVTA) Q2 2021 Earnings Call Transcript [Aug-04-21 09:01AM] Why Invitae Stock Is Climbing Today [Aug-04-21 12:55PM]
04-05-2021	AH	4:05 PM ET (May 4)	NVTA	Invitae Corporation	6,880	-0.63	-0.60	-0.80	Invitae EPS beats by $0.04, beats on revenue [5/4/2021 4:07 PM]	31.23	-0.27 (-0.86%)	31.23	0.0 (0.00%)	15.12 - 61.59	11,773,532	2,930,000	61,965
Invitae EPS beats by $0.04, beats on revenue [5/4/2021 4:07 PM] Invitae posts Q1 revenue beat as growth accelerates [5/4/2021 4:37 PM] Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021 [May-04-21 04:05PM] Shares of Cancer Researchers Exact Sciences and Invitae Are Sliding. Heres Why. [May-04-21 06:09PM] Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 06:55PM] Invitae (NVTA) Q1 2021 Earnings Call Transcript [May-05-21 03:31AM] Invitae Shares Trading Lower As Q1 Earnings Lag Estimates, Contracting Margins [May-05-21 09:53AM]
17-02-2021	AH	4:05 PM ET (Feb 17)	NVTA	Invitae Corporation	9,890	-0.63	-0.58	-0.63	Invitae EPS misses by $0.77, beats on revenue [2/17/2021 4:11 PM]	47.66	-0.20 (-0.42%)	49.50	1.64 (3.43%)	7.42 - 61.59	4,679,702	3,178,294	84,396
Invitae EPS misses by $0.77, beats on revenue [2/17/2021 4:11 PM] Invitae shares down after hours following Q4 EPS miss [2/17/2021 5:44 PM] Why Invitae's Q4 Results Didn't Fire Up Investors [Feb-18-21 06:05AM] Invitae Lifted to Buy on Growth Potential and Cost Controls [Feb-18-21 05:37AM] Recap: Invitae Q4 Earnings [Feb-17-21 04:21PM] Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020 [Feb-17-21 04:05PM] Invitae Corp. to Host Earnings Call [Feb-17-21 02:30PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	NVTA	Invitae Corporation	7,350	-0.62	-0.60	-0.69	Invitae EPS misses by $0.10, beats on revenue [11/5/2020 4:12 PM]	44.89	-0.80 (-1.75%)	44.00	-1.69 (-3.70%)	7.42 - 55.38	3,816,711	2,546,220	10,730

04-08-2020	AH	4:05 PM ET (Aug 4)	NVTA	Invitae Corporation	3,650	-0.77	-0.62	-0.52	Invitae EPS misses by $0.05, beats on revenue [8/4/2020 4:14 PM]	32.57	-0.54 (-1.63%)	30.25	-2.86 (-8.64%)	7.42 - 35.33	3,308,340	1,771,743	41,878

05-05-2020	AH	4:05 PM ET (May 5)	NVTA	Invitae Corporation	1,930	-0.80	-0.84	-0.47	Invitae EPS beats by $0.08, beats on revenue [5/5/2020 4:13 PM]	16.67	0.46 (2.84%)	16.51	-0.16 (-0.96%)	7.42 - 28.75	2,449,256	2,388,334	800